Long-term Adverse Effects After Bariatric Surgery on Bone Density
NCT ID: NCT03410459
Last Updated: 2019-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2018-02-02
2019-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Adverse Effects After Bariatric Surgery on Oesophagus Epithelium
NCT03410849
Skeletal Health in Bariatric Surgery Patients
NCT03331536
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
NCT04087096
Bariatric Surgery and Skeletal Health
NCT01098942
Healthy Body, Healthy Bones After Bariatric Surgery Trial
NCT04279392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on bone mineral density, fracture risk, and body composition ≥ 5 years post-surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric Bypass
Patients ≥ 5 years after laparoscopic gastric bypass receive DEXA (= Dual-energy x-ray absorptiometry) in order to measure bone mass density
DEXA (= Dual-energy x-ray absorptiometry)
measurement of vertebral bone and hip bone mineral density
Sleeve gastrectomy
Patients ≥ 5 years after laparoscopic sleeve gastrectomy receive DEXA (= Dual-energy x-ray absorptiometry) in order to measure bone mass density
DEXA (= Dual-energy x-ray absorptiometry)
measurement of vertebral bone and hip bone mineral density
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DEXA (= Dual-energy x-ray absorptiometry)
measurement of vertebral bone and hip bone mineral density
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bettina K Wölnerhanssen, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research St. Claraspital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Claraspital
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUB Study Bone
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.